Ultragenyx Pharmaceutical | RARE - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Immunic USD -22.78M 753K 2024-06
Insmed USD -314.19M 31.48M 2025-12
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Kyowa Hakko Kirin JPY 45.74B 13.46B 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
Moderna USD -790M 582M 2025-12
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
PTC Therapeutics USD -70.99M 91.62M 2025-12
Puma Biotechnology USD 729K 11.36M 2024-06
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.39B 48.8M 2025-12
Xoma USD 2.52M 7.98M 2024-06